Jey Kumar Pachiyappan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jey Kumar Pachiyappan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Raagul Seenivasan
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India
3 shared publications - Anitha Marimuthu
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India
2 shared publications - Gowthamarajan Kuppusamy
Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, India
2 shared publications - Jawahar Natarajan
Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Nilgiris, Ooty 643001, Tamil Nadu, India
2 shared publications - Praveen Halagali
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India
2 shared publications - Vamshi Krishna Tippavajhala
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India
2 shared publications
Latest Publications
- 9 May 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 512, 142338
Hidden pathways: Detection and quantification of microplastics across treatment stages of pharmaceutical WWTPs
- 9 May 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 512, 142338
Hidden pathways: Detection and quantification of microplastics across treatment stages of pharmaceutical WWTPs
- Open Access
- 31 March 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (4) , 152
Gut microbiota shifts in spaceflight: a case study evidence and countermeasures for microbial homeostasis
The gut microbiota is a crucial component in maintaining overall human health since it has been found to influence not only metabolism but also neurobehavioral function and immunity. The extreme conditions of space, for example, cosmic radiation, microgravity, and confinement, can severely disrupt the functioning and alter the composition of gut microbiota. In fact, this will predispose the immune system to be dysfunctional, lead to psychological and metabolic disorders that are accompanied by a decrease in the diversity of beneficial microbes and change in the pattern of metabolite production. The spaceflight analog and ground, based studies have produced important findings concerning the mechanisms and reasons for gut microbial dysbiosis in extreme conditions. Different research works have been carried out, such as dietary intervention and high fiber to support the growth of healthy microbes. Further, advanced microbial monitoring using wearable sensors to identify the microbial and proinflammatory biomarkers will mitigate dysbiosis and safeguard the crew’s health for longer-duration missions. This wearable sensor will not only help monitor astronauts’ microbial status continuously, but it will also provide a significant feature for designing personalized dietary plans and probiotic supplements. This article provides a comprehensive understanding of astronaut health, including disturbances to the gut microbiome during space travel, space-analogue studies conducted by many researchers to unravel mechanisms, countermeasures to stabilize the gut microbiome, and its prospects.
- 31 March 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (4) , 152
Open AccessGut microbiota shifts in spaceflight: a case study evidence and countermeasures for microbial homeostasis
The gut microbiota is a crucial component in maintaining overall human health since it has been found to influence not only metabolism but also neurobehavioral function and immunity. The extreme conditions of space, for example, cosmic radiation, microgravity, and confinement, can severely disrupt the functioning and alter the composition of gut microbiota. In fact, this will predispose the immune system to be dysfunctional, lead to psychological and metabolic disorders that are accompanied by a decrease in the diversity of beneficial microbes and change in the pattern of metabolite production. The spaceflight analog and ground, based studies have produced important findings concerning the mechanisms and reasons for gut microbial dysbiosis in extreme conditions. Different research works have been carried out, such as dietary intervention and high fiber to support the growth of healthy microbes. Further, advanced microbial monitoring using wearable sensors to identify the microbial and proinflammatory biomarkers will mitigate dysbiosis and safeguard the crew’s health for longer-duration missions. This wearable sensor will not only help monitor astronauts’ microbial status continuously, but it will also provide a significant feature for designing personalized dietary plans and probiotic supplements. This article provides a comprehensive understanding of astronaut health, including disturbances to the gut microbiome during space travel, space-analogue studies conducted by many researchers to unravel mechanisms, countermeasures to stabilize the gut microbiome, and its prospects.
- 4 October 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (8) , 1-24
Advances in Pharmaceutical Cocrystals and Nano-Cocrystals: Strategies for Enhancing Solubility and Translating to Clinical Use
Poor oral bioavailability in most modern pharmaceuticals is primarily caused by poor aqueous solubility. Most NCEs (New Chemical Entities) and nearly 40% o
- 4 October 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (8) , 1-24
Advances in Pharmaceutical Cocrystals and Nano-Cocrystals: Strategies for Enhancing Solubility and Translating to Clinical Use
Poor oral bioavailability in most modern pharmaceuticals is primarily caused by poor aqueous solubility. Most NCEs (New Chemical Entities) and nearly 40% o
- Open Access
- 7 March 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 1-9
ORAL MUCOSITIS INDUCED BY RADIATION/CHEMOTHERAPY; CHALLENGES IN THERAPEUTIC IMPLICATIONS AND FUTURE PROSPECTS
Oral mucositis (OM) is a common and debilitating side effect of cancer treatments, primarily chemotherapy and radiotherapy. Inflammation of the oral mucosa leads to various severe outcomes, which affect the quality of life in patients. Sometimes, inhibition of treatment may be necessary, which may lead to insubstantial evasion of cancer therapy. The review article discusses current prevention and management techniques, such as oral hygiene protocols, cryotherapy, low-level laser therapy, and pharmacological interventions, including palifermin. It also comments on the risk factors that include the type of cancer, treatment protocols, and patient-related factors. It finally speaks about the clinical and economic impact of OM in the treatment of cancer and healthcare systems.
- 7 March 2025
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 1-9
Open AccessORAL MUCOSITIS INDUCED BY RADIATION/CHEMOTHERAPY; CHALLENGES IN THERAPEUTIC IMPLICATIONS AND FUTURE PROSPECTS
Oral mucositis (OM) is a common and debilitating side effect of cancer treatments, primarily chemotherapy and radiotherapy. Inflammation of the oral mucosa leads to various severe outcomes, which affect the quality of life in patients. Sometimes, inhibition of treatment may be necessary, which may lead to insubstantial evasion of cancer therapy. The review article discusses current prevention and management techniques, such as oral hygiene protocols, cryotherapy, low-level laser therapy, and pharmacological interventions, including palifermin. It also comments on the risk factors that include the type of cancer, treatment protocols, and patient-related factors. It finally speaks about the clinical and economic impact of OM in the treatment of cancer and healthcare systems.
- Open Access
- 7 March 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 1-11
ADVANCEMENTS IN MICRONEEDLE TECHNOLOGY: COMPREHENSIVE INSIGHTS INTO VERSATILE DRUG DELIVERY MECHANISMS
Microneedle-based transdermal medication administration is a revolutionary drug delivery technique that has advantages over parenteral and oral drug delivery systems. They are convenient, painless, safe, and effective. Due to the skin’s stratum corneum layer, the majority of drugs only have a limited impact, which constitutes a thickness of about 10 to 15 µm and acts as a barrier for molecules to reach the site of action, allowing just a few molecules to pass through. To overcome this, many researchers have concentrated on using microneedles to bypass the stratum corneum barrier. The main goal of microneedles is to get the drug into the epidermis without disrupting nerve endings. Micron-sized channels created by the skin layer being broken by microneedles transport the medication directly to the epidermis or higher dermis, avoiding the barrier layer and into the systemic circulation. As a result, the microneedle can improve transdermal drug delivery. Microneedles are fabricated in different forms, such as “Solid Microneedles,” “Coated Microneedles,” “Dissolving or Biodegradable Microneedles,” “Hollow Microneedles” and Hydrogel-forming Microneedles, through the use of components including polymers, polysaccharides, silicon, and metals. Micromolding, laser cutting, dip coating, 3D printing and its techniques are just a few of the processes used to make microneedles. Recently, microneedles have become popular for delivering drugs, genes, proteins, RNA and vaccines, demonstrating significant therapeutic effects. A variety of nano-carriers, along with different delivery methods, assist in emphasizing the use of microneedles in the meantime.
- 7 March 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 1-11
Open AccessADVANCEMENTS IN MICRONEEDLE TECHNOLOGY: COMPREHENSIVE INSIGHTS INTO VERSATILE DRUG DELIVERY MECHANISMS
Microneedle-based transdermal medication administration is a revolutionary drug delivery technique that has advantages over parenteral and oral drug delivery systems. They are convenient, painless, safe, and effective. Due to the skin’s stratum corneum layer, the majority of drugs only have a limited impact, which constitutes a thickness of about 10 to 15 µm and acts as a barrier for molecules to reach the site of action, allowing just a few molecules to pass through. To overcome this, many researchers have concentrated on using microneedles to bypass the stratum corneum barrier. The main goal of microneedles is to get the drug into the epidermis without disrupting nerve endings. Micron-sized channels created by the skin layer being broken by microneedles transport the medication directly to the epidermis or higher dermis, avoiding the barrier layer and into the systemic circulation. As a result, the microneedle can improve transdermal drug delivery. Microneedles are fabricated in different forms, such as “Solid Microneedles,” “Coated Microneedles,” “Dissolving or Biodegradable Microneedles,” “Hollow Microneedles” and Hydrogel-forming Microneedles, through the use of components including polymers, polysaccharides, silicon, and metals. Micromolding, laser cutting, dip coating, 3D printing and its techniques are just a few of the processes used to make microneedles. Recently, microneedles have become popular for delivering drugs, genes, proteins, RNA and vaccines, demonstrating significant therapeutic effects. A variety of nano-carriers, along with different delivery methods, assist in emphasizing the use of microneedles in the meantime.